( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Sudhananthini Thangam, Revathi Pitchaipillai*, JeganArokiasamy, Chinthana Govindarajan, Bhuvaneswari Shanmugasundaram, Manickavasagam Subramania Pillai


Rheumatoid Arthritis (RA) is an auto-immune disease predominately affects synovial joints. The clinical hallmark of RA is inflammation of peripheral joints - typically in the hands (metacarpophalangeal joints and proximal interphalangeal joints), causing pain, stiffness and often some degree of irreversible joint damage, deformity and disability. RA can also affect various organs and organ systems including skin, lungs, heart, kidney, nervous system and gastrointestinal tract. Worldwide prevalence of RA was recorded from the range between 2.0 to 10.7 per 1,000 based on the 1987 revised American College of Rheumatology (ACR) criteria. In INDIA, the prevalence is found to be approximately 0.75%. Classification as definite RA is based on the joint American College of Rheumatology (ACR) and the European League against Rheumatism (EULAR) criteria. The management of RA involves the use of Symptom modifying anti rheumatoid drugs (SMARDs) like Non steroidal anti-inflammatory drugs, glucocorticoids and Disease modifying anti rheumatoid drugs (DMARDs) like Methotrexate, Sulphasalazine etc. Statins, introduced to the market as lipid-lowering agents, have been shown to reduce cardiovascular morbidity and mortality. Various trials with statins on RA like TARA trial have proved their efficacy in the management and prevention of risk factors in RA. Pitavastatin, the seventh statin is a new member of the statin family. Being a lipophilic statin it can easily penetrate hepatic and extrahepatic tissues like bone and exert its anti-inflammatory effect. It is proved to be efficacious compared to other statins based on Patrol trial, Lives study and Chiba study. Many studies demonstrated that pitavastatin increases bone resorption in RA. Pitavastatin is proved to be a more safer and efficient adjuvant drug in the management of RA along with DMARDs, particularly in elderly patients.

Keywords: Rheumatoid Arthritis, Statins, Pitavastatin, Synovitis, Inflammation.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 July 2024 Issue has been Published, Kindly check it on


    JULY 2024 issue has been successfully launched on JULY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia